ES2069606T3 - 5-aril-sustituido-2,3-dihidro-imidazo(1,2-a)furo(3,2-c)- o tieno(2,3-c)piridinas. - Google Patents

5-aril-sustituido-2,3-dihidro-imidazo(1,2-a)furo(3,2-c)- o tieno(2,3-c)piridinas.

Info

Publication number
ES2069606T3
ES2069606T3 ES89810333T ES89810333T ES2069606T3 ES 2069606 T3 ES2069606 T3 ES 2069606T3 ES 89810333 T ES89810333 T ES 89810333T ES 89810333 T ES89810333 T ES 89810333T ES 2069606 T3 ES2069606 T3 ES 2069606T3
Authority
ES
Spain
Prior art keywords
piridinas
tieno
furo
imidazo
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89810333T
Other languages
English (en)
Inventor
Seung Hoon Cheon
William Joseph Houlihan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of ES2069606T3 publication Critical patent/ES2069606T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA(I) (EN LA QUE LOS SUSTITUYENTES TIENEN DIVERSOS SIGNIFICADOS), QUE SE PUEDEN PREPARAR POR DESHIDRATACION Y ESTAN INDICADOS PARA EMPLEO COMO INHIBIDORES DEL FACTOR DE ACTIVACION DE PLAQUETAS (FAP) Y COMO AGENTES ANTITUMORALES.
ES89810333T 1988-05-05 1989-05-01 5-aril-sustituido-2,3-dihidro-imidazo(1,2-a)furo(3,2-c)- o tieno(2,3-c)piridinas. Expired - Lifetime ES2069606T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19056688A 1988-05-05 1988-05-05

Publications (1)

Publication Number Publication Date
ES2069606T3 true ES2069606T3 (es) 1995-05-16

Family

ID=22701867

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89810333T Expired - Lifetime ES2069606T3 (es) 1988-05-05 1989-05-01 5-aril-sustituido-2,3-dihidro-imidazo(1,2-a)furo(3,2-c)- o tieno(2,3-c)piridinas.

Country Status (13)

Country Link
EP (1) EP0341213B1 (es)
JP (1) JPH01319484A (es)
AT (1) ATE118777T1 (es)
AU (1) AU626295B2 (es)
CA (1) CA1334754C (es)
DE (1) DE68921239T2 (es)
DK (1) DK218989A (es)
ES (1) ES2069606T3 (es)
IE (1) IE891445L (es)
IL (1) IL90172A (es)
NZ (1) NZ228968A (es)
PH (1) PH26151A (es)
ZA (1) ZA893343B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781482B1 (fr) * 1998-07-27 2001-08-31 Adir Nouveaux derives de 8h-thieno-[2,3-b]pyrrolizine-8-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0765198B2 (ja) * 1986-06-27 1995-07-12 三洋電機株式会社 ドライエツチングプロセスの評価方法
EP0258175B1 (en) * 1986-07-14 1992-04-01 Sandoz Ag 5-hetero- or aryl-substituted-imidazo[2,1-a]isoquinolines

Also Published As

Publication number Publication date
PH26151A (en) 1992-03-18
IE891445L (en) 1989-11-05
AU3397789A (en) 1989-11-09
DK218989A (da) 1989-11-06
AU626295B2 (en) 1992-07-30
IL90172A (en) 1992-11-15
IL90172A0 (en) 1989-12-15
ATE118777T1 (de) 1995-03-15
DE68921239D1 (de) 1995-03-30
DK218989D0 (da) 1989-05-03
CA1334754C (en) 1995-03-14
EP0341213B1 (en) 1995-02-22
EP0341213A2 (en) 1989-11-08
NZ228968A (en) 1992-01-29
DE68921239T2 (de) 1995-09-14
EP0341213A3 (en) 1991-05-29
ZA893343B (en) 1991-01-30
JPH01319484A (ja) 1989-12-25

Similar Documents

Publication Publication Date Title
DK381583A (da) Metylsubstituerede 4-metoxypyridin-n-oxyder
NO900306D0 (no) Fremgangsmaate for fremstilling av nye pyrazolopyridin-forbindelser.
ES479206A1 (es) Un procedimiento para la preparacion de n-heterociclil-4- piperidinamina.
MX9428A (es) Tienopiridinonas y procedimiento para su preparacion
KR900701280A (ko) 토포이소메라제 억제제 또는 세포 분화 유도제로서의 5환형 트리테르페노이드 화합물
ATE118777T1 (de) 5-aryl-substituierte-2,3-dihydro-imidazo(1,2- a>furo(3,2-c>- oder thieno(2,3-c>pyridine.
FI884017A0 (fi) Pyrrolo /1,2-a/ imidazol- och imidazo /1,2-a/-pyridinderivat och anvaendning daerav som inhibitorer av 5-lipoxigenasstigen.
FI842112A0 (fi) Foerfarande foer framstaellning av- karbolin-3-karboxylsyraderivat.
MA19817A1 (fr) Nouveaux derives du thioformamide et leur preparation .
SE7902915L (sv) 4-oxo-4h-pyrido(1,2-a)pyrimidin-3-n-(1h-tetrazol-5-yl) karboxamidderivat och deras anvendning sasom inhibitorer av allergiska reaktioner
FI902360A0 (fi) 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
ES2053590T3 (es) 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados.
MY103521A (en) Bicyclocatechol derivatives
JPS523096A (en) Preparation of furo- 3,2-b indoles
JPS5353697A (en) Tricyclic triazolopyrimidine derivatives
JPS52100496A (en) Synthesis of pyrrolothienodiazepins and acid addition salts thereof
JPS5298000A (en) Preparation of novel dihydrofurocoumarin derivatives
JPS5439017A (en) Novel organic sulfonic acid esters and their preparation
JPS5430198A (en) Pyrido(2,3-b) phenothiazines
JPS5212167A (en) Chroman derivatives
PT72573A (pt) Process for the preparation of novel animinium salts and its 5-(cyano or carbamyl)-/3,4-bipyridin/-6(1h)-one derivates
JPS5353647A (en) 7-oxo-6-azabicyclo 3,2,1 oct-2-ene-2,8-dicarboxylic acid derivatives, theirmolecular compounds and preparation
JPS5697292A (en) Benzothiazolidine derivative
JPS52144696A (en) Novel pyrido (2,3-d) pyprole (1,2-a) pyrimidine derivatives
JPS5283588A (en) Thiazolopyridine-carboxylic acid derivatives

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 341213

Country of ref document: ES